WO2005062723A3 - An improved process for the preparation of 7-chloro-4-(5-n-ehtyl-n-2-hydroxyethylamine)-2-pentyl] aminoquinoline and its intermediates - Google Patents
An improved process for the preparation of 7-chloro-4-(5-n-ehtyl-n-2-hydroxyethylamine)-2-pentyl] aminoquinoline and its intermediates Download PDFInfo
- Publication number
- WO2005062723A3 WO2005062723A3 PCT/IN2004/000364 IN2004000364W WO2005062723A3 WO 2005062723 A3 WO2005062723 A3 WO 2005062723A3 IN 2004000364 W IN2004000364 W IN 2004000364W WO 2005062723 A3 WO2005062723 A3 WO 2005062723A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chloro
- aminoquinoline
- intermediates
- pentyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1215/MUM/2003 | 2003-11-24 | ||
IN1213/MUM/2003 | 2003-11-24 | ||
IN1213MU2003 | 2003-11-24 | ||
IN1215MU2003 | 2003-11-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005062723A2 WO2005062723A2 (en) | 2005-07-14 |
WO2005062723A3 true WO2005062723A3 (en) | 2006-01-05 |
Family
ID=34740782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2004/000364 WO2005062723A2 (en) | 2003-11-24 | 2004-11-23 | An improved process for the preparation of 7-chloro-4-(5-n-ehtyl-n-2-hydroxyethylamine)-2-pentyl] aminoquinoline and its intermediates |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005062723A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101115412B1 (en) * | 2008-09-08 | 2012-06-12 | 주식회사 대희화학 | New preparation of hydroxychloroquine |
CN104230803B (en) * | 2014-08-28 | 2017-02-01 | 重庆康乐制药有限公司 | Preparation method of hydroxychloroquine sulfate |
WO2019165337A1 (en) * | 2018-02-26 | 2019-08-29 | Virginia Commonwealth University | High-yielding continuous flow synthesis of antimalarial drug hydroxychloroquine |
CN109456266A (en) * | 2018-11-12 | 2019-03-12 | 南京天际联盟医药科技有限公司 | The novel preparation method of hydroxychloroquine sulfate |
CN110283121A (en) * | 2019-08-06 | 2019-09-27 | 华东理工大学 | The synthetic method of hydroxychloroquine |
CN111482178A (en) * | 2020-04-15 | 2020-08-04 | 中国科学院兰州化学物理研究所 | Supported nano nickel-based catalyst and preparation method and application thereof |
CN111635358B (en) * | 2020-06-29 | 2022-06-03 | 北京成宇化工有限公司 | Preparation method of hydroxychloroquine |
CN111995574A (en) * | 2020-08-28 | 2020-11-27 | 西安明喆药品生产有限公司 | Deuterated hydroxychloroquine derivative and pharmaceutical composition containing same |
IT202000020872A1 (en) | 2020-09-02 | 2022-03-02 | Dipharma Francis Srl | PROCEDURE FOR THE PREPARATION OF AN AGENT FOR THE TREATMENT OF MALARIA |
CN112300071B (en) * | 2020-11-25 | 2023-01-31 | 威胜生物医药(苏州)股份有限公司 | Synthetic method of high-purity chloroquine phosphate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3362954A (en) * | 1965-08-12 | 1968-01-09 | Sterling Drug Inc | 4-tertiary amino-lower alkylamino-quinoline carboxamides and carboxylates |
US5314894A (en) * | 1992-09-15 | 1994-05-24 | Sterling Winthrop Inc. | (S)-(+)-hydroxychloroquine |
-
2004
- 2004-11-23 WO PCT/IN2004/000364 patent/WO2005062723A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3362954A (en) * | 1965-08-12 | 1968-01-09 | Sterling Drug Inc | 4-tertiary amino-lower alkylamino-quinoline carboxamides and carboxylates |
US5314894A (en) * | 1992-09-15 | 1994-05-24 | Sterling Winthrop Inc. | (S)-(+)-hydroxychloroquine |
Non-Patent Citations (2)
Title |
---|
BAILEY D. ET AL.: "Quinoline Antimalarials. Folded Chloroquine", JOURNAL OF MEDICINAL CHEMISTRY, vol. 12, no. 1, January 1969 (1969-01-01), pages 184 - 185, XP002337636 * |
LANGER S. ET AL.: "Inhibitors of Topoisomerase II", CLINICAL CANCER RESEARCH, vol. 5, October 1999 (1999-10-01), pages 2899 - 2907, XP002991582 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005062723A2 (en) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005062723A3 (en) | An improved process for the preparation of 7-chloro-4-(5-n-ehtyl-n-2-hydroxyethylamine)-2-pentyl] aminoquinoline and its intermediates | |
WO2003089618A3 (en) | Transposon system and methods of use | |
AU2002322280A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
AP1869A (en) | b2- Adrenergic receptor agonists. | |
WO2004018999A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
AU2002337657A1 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
WO2003029262A3 (en) | The human mob-5 (il-24) receptors and uses thereof | |
AU2002365166A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis | |
WO2006060513A3 (en) | Toll like receptor 3 antagonists, methods and uses | |
MXPA03006260A (en) | Substituted amine derivatives and methods of use. | |
CA2362185A1 (en) | Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof | |
WO2006121767A3 (en) | 4-aminoquinoline compounds for treating virus-related conditions | |
IS6350A (en) | β2-adrenergic receptor agonists | |
WO2004052899A3 (en) | Process for the production of 2'-branched nucleosides | |
WO2002088085A3 (en) | Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors | |
AU2002324451A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer | |
AU2074201A (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
WO2001062705A8 (en) | Aminoalcohol derivatives | |
CA2330447A1 (en) | N-(3-ethynylphenyl-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate | |
WO2007023115A3 (en) | P38 map kinase inhibitors and methods for using the same | |
WO2003099217A3 (en) | Methods of treating bacterial infections and diseases associated therewith | |
WO2005089505A3 (en) | Detection, isolation and uses of renalase (monoamine oxidase c) | |
WO2005008251A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis | |
WO2006029253A3 (en) | A valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard | |
WO2002059084A3 (en) | Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |